What’s Going on with Lamotrigine (Lamictal)? An Updated Look at the Popular Medication for Bipolar Disorder

References

• Bahji, A., Ermacora, D., Stephenson, C., Hawken, E. R., & Vazquez, G. (2020). Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: A systematic review and network meta-analysis. Journal of Affective Disorders, 269, 154–184. https://doi.org/10.1016/j.jad.2020.03.030
   PubMed Web of Science ®Google Scholar
• Besag, F., Vasey, M. J., Sharma, A. N., & Lam, I. (2021). Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: A systematic review. Therapeutic Advances in Psychopharmacology, 11. https://doi.org/10.1177/20451253211045870
   Google Scholar
• Christensen, J., Trabjerg, B. B., & Dreier, J. W. (2022). Cardiac morbidity and mortality associated with the use of lamotrigine. Epilepsia. https://doi.org/10.1111/epi.17339
   Google Scholar
• Coles, A. S., Sasiadek, J., & George, T. P. (2019). Pharmacotherapies for co-occurring substance use and bipolar disorders: A systematic review. Bipolar Disorders, 21(7), 595–610. https://doi.org/10.1111/bdi.12794
   PubMed Web of Science ®Google Scholar
• Goh, K. K., Chen, C. H., Chiu, Y. H., & Lu, M. L. (2019). Lamotrigine augmentation in treatment-resistant unipolar depression: A comprehensive meta-analysis of efficacy and safety. Journal of Psychopharmacology, 33(6), 700–713. https://doi.org/10.1177/0269881119844199
   PubMed Web of Science ®Google Scholar
• Hashimoto, Y., Kotake, K., Watanabe, N., Fujiwara, T., & Sakamoto, S. (2021). Lamotrigine in the maintenance treatment of bipolar disorder. The Cochrane Database of Systematic Reviews, 9(9) https://doi.org/10.1002/14651858.CD013575.pub2
   Google Scholar
• Hussain, A., Shah, M. S., Roub, F. E., Dar, M. A., Wani, Z. A., Jan, M. M., Wani, R. A., & Bhat, T. A. (2015). Seasonal affective disorder (SAD): Role of lamotrigine augmentation to anti-depressant medication in winter depression. Indian Journal of Psychological Medicine, 37(3), 272–276. https://doi.org/10.4103/0253-7176.162916
   PubMedGoogle Scholar
• Ingleby-Talecki, L., Dijkman, S. C., Oosterholt, S. P., Della Pasqua, O., Winter, C., Cunnington, M., Rebar, L., Forero‐Schwanhaeuser, S., Patel, V., Cooper, J. A., Bahinski, A., & Chaudhary, K. W. (2022). Cardiac sodium channel inhibition by lamotrigine: In vitro characterization and clinical implications. Clinical and Translational Science. https://doi.org/10.1111/cts.13311
   Google Scholar
• Khalkhali, M., Aram, S., Zarrabi, H., Kafie, M., & Heidarzadeh, A. (2016). Lamotrigine augmentation versus placebo in serotonin ­reuptake inhibitors-resistant obsessive- compulsive disorder: A randomized controlled trial. Iranian Journal of Psychiatry, 11(2), 104–114.
   PubMedGoogle Scholar
• Kishi, T., Ikuta, T., Matsuda, Y., Sakuma, K., Okuya, M., Mishima, K., & Iwata, N. (2021a). Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: A systematic review and network meta-analysis of randomized controlled trials. Molecular Psychiatry, 26(8), 4146–4157. https://doi.org/10.1038/s41380-020-00946-6
   PubMed Web of Science ®Google Scholar
• Kishi, T., Matsuda, Y., Sakuma, K., Okuya, M., Mishima, K., & Iwata, N. (2021b). Recurrence rates in stable bipolar disorder patients after drug discontinuation versus drug maintenance: A systematic review and meta-analysis. Psychological Medicine, 51(15), 2730. https://doi.org/10.1017/S0033291721001033
   PubMed Web of Science ®Google Scholar
• Miura, T., Noma, H., Furukawa, T. A., Mitsuyasu, H., Tanaka, S., Stockton, S., Salanti, G., Motomura, K., Shimano-Katsuki, S., Leucht, S., Cipriani, A., Geddes, J. R., & Kanba, S. (2014). Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: A systematic review and network meta- analysis. The Lancet. Psychiatry, 1(5), 351–359. https://doi.org/10.1016/S2215-0366(14)70314-1
   PubMed Web of Science ®Google Scholar
• Parker, G., Ricciardi, T., Tavella, G., & Hadzi-Pavlovic, D. (2021). A single-blind randomized comparison of lithium and lamotrigine as maintenance treatments for managing bipolar II disorder. Journal of Clinical Psychopharmacology, 41(4), 381–388. https://doi.org/10.1097/JCP.0000000000001424
   PubMed Web of Science ®Google Scholar
• Reilly, E. E., Berner, L. A., Trunko, M. E., Schwartz, T., Anderson, L. K., Krueger, A., Yu, X., Chen, J. Y., Cusack, A., Nakamura, T., & Kaye, W. H. (2022). Evaluating the use of lamotrigine to reduce mood lability and impulsive behaviors in adults with chronic and severe eating disorders. Eating and Weight Disorders: EWD, 27(5), 1775–1785. https://doi.org/10.1007/s40519-021-01320-3
   PubMed Web of Science ®Google Scholar
• Restrepo, J. A., MacLean, R., Celano, C. M., Huffman, J. C., Januzzi, J. L., & Beach, S. R. (2022). The assessment of cardiac risk in patients taking lamotrigine; a systematic review. General Hospital Psychiatry, 78, 14–27. https://doi.org/10.1016/j.genhosppsych.2022.06.004
   PubMed Web of Science ®Google Scholar
• Roosen, L., & Sienaert, P. (2022). Evidence-based treatment strategies for rapid cycling bipolar disorder, a systematic review. Journal of Affective Disorders, 311, 69–77. https://doi.org/10.1016/j.genhosppsych.2022.06.004
   PubMed Web of Science ®Google Scholar
• Solmi, M., Veronese, N., Zaninotto, L., van der Loos, M. L., Gao, K., Schaffer, A., Reis, C., Normann, C., Anghelescu, I. G., & Correll, C. U. (2016). Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: A comprehensive meta-analysis of efficacy and safety outcomes in short-term trials. CNS Spectrums, 21(5), 403–418. https://doi.org/10.1017/S1092852916000523
   PubMed Web of Science ®Google Scholar
• Terao, T., Ishida, A., Kimura, T., Yarita, M., & Hara, T. (2017). Preventive effects of lamotrigine in bipolar II versus bipolar I disorder. The Journal of Clinical Psychiatry, 78(8), e1000–e1005. https://doi.org/10.4088/JCP.16m11404
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. (2021). Studies show increased risk of heart rhythm problems with seizure and mental health medicine lamotrigine (Lamictal) in patients with heart disease. https://www.fda.gov/drugs/drug-safety-and-availability/studies-show-increased-risk-heart-rhythm-problems-seizure-and-mental-health-medicine-lamotrigine
   Google Scholar
• Uguz, F. (2020). Pharmacological prevention of mood episodes in women with bipolar disorder during the perinatal period: A systematic review of current literature. Asian Journal of Psychiatry, 52, 102145. https://doi.org/10.1016/j.ajp.2020.102145
   PubMed Web of Science ®Google Scholar
• Zhou, D. D., Zhou, X. X., Li, Y., Zhang, K. F., Lv, Z., Chen, X. R., Wan, L. Y., Wang, W., Wang, G. M., Li, D. Q., Ai, M., & Kuang, L. (2019). Augmentation agents to serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder: A network meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 90, 277–287. https://doi.org/10.1016/j.pnpbp.2018.12.009
   PubMed Web of Science ®Google Scholar